|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Provision for expected credit losses | |||||
| Deferred income tax benefit | |||||
| Share-based compensation expense | |||||
| Gain on disposal of fixed assets | |||||
| Amortization of discount on accounts receivable | |||||
| Amortization of right-of-use assets | |||||
| Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Vendor prepayments | |||||
| Accounts payable and accrued expenses | |||||
| Lease liability, net | |||||
| Other assets and liabilities | |||||
| Net cash and cash equivalents provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of equipment and leasehold improvements | |||||
| Payment for acquisitions, net of cash acquired | |||||
| Net cash and cash equivalents used in investing activities | |||||
| Cash flows from financing activities | |||||
| Purchase of treasury stock | |||||
| Borrowings under credit facilities | |||||
| Repayments of borrowings under credit facilities | |||||
| Repayments of borrowings under term loan | |||||
| Dividends paid | |||||
| Contingent consideration | |||||
| Payments of deferred financing costs | |||||
| Net cash and cash equivalents used in financing activities | |||||
| Effect of foreign exchange rate on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Effect of foreign exchange rate on cash and cash equivalents | |||||
| Supplementary disclosure of cash flow information: | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Supplementary disclosure of non-cash investing and financing activities: | |||||
| Contingent earn-out | |||||
Loading...